An inverse association appears to emerge between bradykinin and its related peptides and progression of DN in more advanced DN [37], perhaps as the activation of B1R becomes more prominent, but the timing and determinants of this putative transition are presently unknown. This evidence concerns the gene BDKRB1 and liver dysplastic nodule.